Cargando…

Bioactive VEGF-C from E. coli

Vascular endothelial growth factor-C (VEGF-C) stimulates lymphatic vessel growth in transgenic models, via viral gene delivery, and as a recombinant protein. Expressing eukaryotic proteins like VEGF-C in bacterial cells has limitations, as these cells lack specific posttranslational modifications an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rauniyar, Khushbu, Akhondzadeh, Soheila, Gąciarz, Anna, Künnapuu, Jaana, Jeltsch, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616921/ https://www.ncbi.nlm.nih.gov/pubmed/36307539 http://dx.doi.org/10.1038/s41598-022-22960-0

Ejemplares similares

Proteolytic Cleavages in the VEGF Family: Generating Diversity among Angiogenic VEGFs, Essential for the Activation of Lymphangiogenic VEGFs
por: Künnapuu, Jaana, et al.
Publicado: (2021)

Expansion and collapse of VEGF diversity in major clades of the animal kingdom
por: Rauniyar, Khushbu, et al.
Publicado: (2023)

Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1
por: Jha, Sawan Kumar, et al.
Publicado: (2017)

KLK3/PSA and cathepsin D activate VEGF-C and VEGF-D
por: Jha, Sawan Kumar, et al.
Publicado: (2019)

Biology of Vascular Endothelial Growth Factor C in the Morphogenesis of Lymphatic Vessels
por: Rauniyar, Khushbu, et al.
Publicado: (2018)

KLK3 in the Regulation of Angiogenesis—Tumorigenic or Not?
por: Koistinen, Hannu, et al.
Publicado: (2021)

Systematic screening of soluble expression of antibody fragments in the cytoplasm of E. coli
por: Gaciarz, Anna, et al.
Publicado: (2016)

Expression, purification and functionality of bioactive recombinant human vascular endothelial growth factor VEGF(165) in E. coli
por: Taktak-BenAmar, Awatef, et al.
Publicado: (2017)

Alginate hydrogels allow for bioactive and sustained release of VEGF-C and VEGF-D for lymphangiogenic therapeutic applications
por: Campbell, Kevin T., et al.
Publicado: (2017)

Complementarity determining regions and frameworks contribute to the disulfide bond independent folding of intrinsically stable scFv
por: Gąciarz, Anna, et al.
Publicado: (2017)

Recombinant Production of Snakin-2 (an Antimicrobial Peptide from Tomato) in E. coli and Analysis of Its Bioactivity
por: Herbel, Vera, et al.
Publicado: (2015)

Investigation on the role of biallelic variants in VEGF‐C found in a patient affected by Milroy‐like lymphedema
por: Mukenge, Sylvain, et al.
Publicado: (2020)

Anti-VEGF Effect of Bioactive Indolic Compounds and Hydroxytyrosol Metabolites
por: Gallardo-Fernández, Marta, et al.
Publicado: (2022)

Efficient soluble expression of disulfide bonded proteins in the cytoplasm of Escherichia coli in fed-batch fermentations on chemically defined minimal media
por: Gąciarz, Anna, et al.
Publicado: (2017)

Production of bioactive chicken (Gallus gallus) follistatin-type proteins in E. coli
por: Lee, Sang Beum, et al.
Publicado: (2015)

VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia
por: Gerhardt, Holger, et al.
Publicado: (2003)

Engineered E. coli Nissle 1917 for delivery of bioactive IL-2 for cancer immunotherapy
por: Tumas, Sarunas, et al.
Publicado: (2023)

Peptide-Modified Nano-Bioactive Glass for Targeted Immobilization of Native VEGF
por: Schumacher, Matthias, et al.
Publicado: (2022)

Refolding of bioactive human epidermal growth factor from E. coli BL21(DE3) inclusion bodies & evaluations on its in vitro & in vivo bioactivity
por: Maksum, Iman Permana, et al.
Publicado: (2022)

Plasmin Activates the Lymphangiogenic Growth Factors VEGF-C and VEGF-D
por: McColl, Bradley K., et al.
Publicado: (2003)

The Effect of Low-Level Laser on Postoperative Pain After Elective Cesarean Section
por: Poursalehan, Sara, et al.
Publicado: (2018)

Anti-VEGF Signalling Mechanism in HUVECs by Melatonin, Serotonin, Hydroxytyrosol and Other Bioactive Compounds
por: Cerezo, Ana B., et al.
Publicado: (2019)

Expression analysis and clinical significance of eIF4E, VEGF-C, E-cadherin and MMP-2 in colorectal adenocarcinoma
por: Gao, Minna, et al.
Publicado: (2016)

MB109 as bioactive human bone morphogenetic protein-9 refolded and purified from E. coli inclusion bodies
por: Kuo, Mario Meng-Chiang, et al.
Publicado: (2014)

Evaluation of the antimicrobial attribute of bioactive peptides derived from colostrum whey fermented by Lactobacillus against diarrheagenic E. coli strains
por: Kashyap, Reenu, et al.
Publicado: (2022)

Promoting early neovascularization of SIS-repaired abdominal wall by controlled release of bioactive VEGF
por: Tang, Rui, et al.
Publicado: (2018)

Interactions of Aminopropyl–Azithromycin Derivatives, Precursors in the Synthesis of Bioactive Macrozones, with E. coli Ribosome: NMR and Docking Studies
por: Mikulandra, Ivana, et al.
Publicado: (2021)

Migration-promoting role of VEGF-C and VEGF-C binding receptors in human breast cancer cells
por: Timoshenko, A V, et al.
Publicado: (2007)

Maltose binding protein-fusion enhances the bioactivity of truncated forms of pig myostatin propeptide produced in E. coli
por: Lee, Sang Beum, et al.
Publicado: (2017)

Inhibition of VEGF-Induced VEGFR-2 Activation and HUVEC Migration by Melatonin and Other Bioactive Indolic Compounds
por: Cerezo, Ana B., et al.
Publicado: (2017)

DNA methylation regulates expression of VEGF-C, and S-adenosylmethionine is effective for VEGF-C methylation and for inhibiting cancer growth
por: Da, M.X., et al.
Publicado: (2014)

Engineering E. coli–E. coli cocultures for production of muconic acid from glycerol
por: Zhang, Haoran, et al.
Publicado: (2015)

High Yield Production of a Soluble Human Interleukin-3 Variant from E. coli with Wild-Type Bioactivity and Improved Radiolabeling Properties
por: Hercus, Timothy R., et al.
Publicado: (2013)

Zebrafish ProVEGF-C Expression, Proteolytic Processing and Inhibitory Effect of Unprocessed ProVEGF-C during Fin Regeneration
por: Khatib, Abdel-Majid, et al.
Publicado: (2010)

Complex formation of anti‐VEGF‐C with VEGF‐C released during blood coagulation resulted in an artifact in its serum pharmacokinetics
por: Bumbaca Yadav, Daniela, et al.
Publicado: (2020)

Associations of nm23H1, VEGF-C, and VEGF-3 Receptor in Human Prostate Cancer
por: Yang, Zui-Su, et al.
Publicado: (2014)

VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours
por: Ohta, Y, et al.
Publicado: (1999)

VEGF-C Is a Thyroid Marker of Malignancy Superior to VEGF-A in the Differential Diagnostics of Thyroid Lesions
por: Woliński, Kosma, et al.
Publicado: (2016)

Lymphangiogenesis in Gastric Cancer regulated through Akt/mTOR-VEGF-C/VEGF-D axis
por: Chen, Hongxia, et al.
Publicado: (2015)

Glycation of fibronectin inhibits VEGF‐induced angiogenesis by uncoupling VEGF receptor‐2‐c‐Src crosstalk
por: Chen, Tangting, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h7dcntmnmccol52jo09cqo1l3b